Page 44 - 南京医科大学自然版
P. 44

第46卷第10期
               ·1474 ·                           南 京    医 科 大 学 学         报                        2026年10月


                     Reference  [ 59 ]  [ 60 ]  [ 61 ]  [ 62 ]  [ 63 ]  [ 39 ]  [ 38 ]  [ 64 ]  [ 66 ]  [ 68 ]  [ 70 ]  [ 71 ]  [ 73 ]  [ 72 ]  [ 37 ]  [ 76 ]  [ 78 ]  [ 79 ]  [ 82 ]



                                                                            to                           pro⁃  and



                     Functional impact Involved in PCOS development and  Participates in PCOS pathological  Affects follicular development  Regulates ovarian steroidogenesis  Affects cholesterol metabolism in  Potentially associated with abnormal  Inhibits granulosa cell apoptosis and  Improves inflammatory status of  Impairs embryo attachment Causes embryonic arrest at the  decidualization, leading abnormal embryo implantation May be a key pathogenic mechanism of RIF  Associated with dimini






                  reproductive  progression  process  Increases risk of PCOS  Increases risk of PCOS  ovarian granulosa cells  lipid metabolism in PCOS  restores ovarian function  granulosa cells  morula stage  with Interferes  cells,  Inhibits




                  female           axon     miR⁃1294              inhibits             phagocytosis  mitochondrial  PTEN, activates


                  with                      with  and upregulates  and  TLR4                     and          etc. )
                  associated  Target/Signaling pathway Regulates oxidative stress and cell proliferation in granulosa cells Inhibits granulosa cell proliferation  Regulates glycolysis in granulosa cells  Modulates MAPK signaling,  and circadian rhythm  network  ceRNA  Insulin/MAPK signaling pathway  regulates  Downregulates FOXO1  Abnormal exosome secretion and  mediated and mTOR signaling pathway  glycolytic  Targets and inhibits SLC7A11  inhibits  and  Regulates apoptosis related genes  Tr



                  molecules          guidance,  Forms  and CYP19A1  Binds miR⁃4644  LDLR expression  -  Targets PDCD4  Negatively  κB pathway  NF  Regulates IGF1R  -  function  receptor  Fcγ  Regulates  gene transcription  Targets  PI3K/AKT pathway  Irak,  ( Bim,



                  bioactive 女性生殖疾病相关外泌体非编码RNA及其他生物活性分子


                  other  Sample source  Follicular fluid  Follicular fluid  Follicular fluid  Plasma exosomal  Follicular fluid  Follicular fluid  Follicular fluid  exosomes(obese PCOS  Urinary exosomes  Stem cell exosomes  Stem cell exosomes  Endometrial exosomes  Endometrial exosomes  Plasma derived exosomes  Endometrial exosomes  Follicular fluid exosomes  Follicular fluid exosomes  Serum exosomes  Stem cell exosomes  Stem cell exosomes

                  and    exosomes  exosomes  exosomes  exosomes  exosomes  patients)

                  RNAs                                                           CD9↑

                  coding                                     ( ADSCs derived)  ( hUC MSCs  in           ( BMSCs derived)  ( AFSCs derived)

                表1  non  Expression/Functional change  Differentially expressed  Androgen induced  specific upregulation  Differentially expressed  Significantly elevated  Aberrant expression  Decreased expression  Significantly differentially  Elevated level  Significantly elevated  Aberrant expression  Differentially expressed  and CD9↓  proliferative phase;  in secretory phase Significantly upregulated  Significantly downregulated  Significantly downregulated  in older women
                  Exosomal             Decreased     expressed  Delivered  Delivered  derived)  CD63↑  Carried  Delivered  Delivered




                  1                    miR⁃106a⁃5p,
                  Table                            PTOV1⁃AS1,  SNHG14,                      miR⁃122⁃5p,
                     Molecule name  miR⁃143⁃3p/miR⁃155⁃5p  others                       and   others        miR⁃146a

                       miR⁃4449  miR⁃379⁃5p  miR⁃146a⁃5p,  miR⁃126⁃3p  miR⁃20b⁃5p,  miR⁃18a⁃3p  hsa⁃circ⁃0006877  circ_0008285  TPT1⁃AS1,  PTPRG⁃AS1,  16  and  DENND1A.V2  miR⁃323⁃3p  miR⁃100  miR⁃145  miR⁃218⁃5p  miR⁃183⁃5p  CD9 CD63,  miR⁃625⁃3p,  miR⁃675⁃3p,  others  17  miR⁃1246,  33  and  miR⁃320a⁃3p  miR⁃132⁃5p  miR⁃144⁃5p  miR⁃10a,




                     Molecule type  miRNA  miRNA  miRNA  miRNA  miRNA  circRNA  circRNA  lncRNA  RNA  miRNA  ( therapeutic)  miRNA  ( therapeutic)  miRNA  miRNA  miRNA  Surface marker  miRNA  miRNA  miRNA  miRNA  ( treatment)  miRNA  ( treatment)





                     Disease  PCOS                                   RIF              DOR/POF
   39   40   41   42   43   44   45   46   47   48   49